We measured serum anti-SPTBN1 and anti-CBX3 IgA levels in patients with IgAN (n = 119) and other kidney diseases (disease control [DC], n = 51) using 2 independent cohorts, 1 from Japan and 1 from the UK. This evidence concerns the gene SPTBN1 and kidney disorder.